15 January 2024
15 January 2024
The UK nod for Agamree, which comes after previous approvals in Europe and the US, provides access to a corticosteroid with less severe side effects.
In an update, the FDA reported that it is yet to find a definitive association between GLP-1RA use and suicidal thoughts.
The US Department of Defense procurement contract for Emergent’s BioThrax is comprised of an initial five-year base agreement.
GlobalData has predicted that the drug will see initial success in the growing Chinese market.
According to KOLs interviewed by GlobalData, the industry requires updated diagnostic and management tools.
The acquired programme consists of antibiotics against gram-negative bacteria, including multidrug-resistant strains.
Dermavant will include these findings in an upcoming supplemental new drug application (sNDA) submission, which is expected in Q1 2024.
The funding will enable 3M to develop solutions for infection prevention, wound management and healing.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials.
Give your business an edge with our leading industry insights.
